rexulti brexpiprazole 4 mg film coated tablets blisters
lundbeck australia pty ltd - brexpiprazole, quantity: 4 mg - tablet, film coated - excipient ingredients: magnesium stearate; hyprolose; maize starch; microcrystalline cellulose; lactose monohydrate; titanium dioxide; hypromellose; purified talc - rexulti is indicated in adult patients for the treatment of schizophrenia.
rexulti brexpiprazole 2 mg film coated tablets blisters
lundbeck australia pty ltd - brexpiprazole, quantity: 2 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; microcrystalline cellulose; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide black - rexulti is indicated in adult patients for the treatment of schizophrenia.
rexulti brexpiprazole 3 mg film coated tablets blisters
lundbeck australia pty ltd - brexpiprazole, quantity: 3 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; hyprolose; maize starch; titanium dioxide; hypromellose; purified talc; iron oxide red; iron oxide black - rexulti is indicated in adult patients for the treatment of schizophrenia.
rexulti brexpiprazole 1 mg film coated tablets blisters
lundbeck australia pty ltd - brexpiprazole, quantity: 1 mg - tablet, film coated - excipient ingredients: magnesium stearate; hyprolose; lactose monohydrate; maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow - rexulti is indicated in adult patients for the treatment of schizophrenia.
abilify maintena aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection vial
lundbeck australia pty ltd - aripiprazole, quantity: 400 mg (equivalent: aripiprazole monohydrate, qty 416.07 mg) - injection, diluent for - excipient ingredients: water for injections - for the acute and maintenance treatment of schizophrenia in adults. for maintenance treatment to prevent the recurrence of manic or mixed episodes of bipolar i disorder in adult patients as monotherapy.
abilify maintena aripiprazole (as monohydrate) 300 mg powder and solvent for prolonged release suspension for injection vial
lundbeck australia pty ltd - aripiprazole, quantity: 300 mg (equivalent: aripiprazole monohydrate, qty 312.05 mg) - injection, diluent for - excipient ingredients: water for injections - for the acute and maintenance treatment of schizophrenia in adults. for maintenance treatment to prevent the recurrence of manic or mixed episodes of bipolar i disorder in adult patients as monotherapy.
lexapro escitalopram (as oxalate) 20 mg/ml oral solution bottle
lundbeck australia pty ltd - escitalopram oxalate, quantity: 25.551 mg/ml (equivalent: escitalopram, qty 20 mg/ml) - oral liquid, solution - excipient ingredients: sodium hydroxide; ethanol; purified water; propyl gallate; citric acid - treatment of major depression. treatment of social anxiety disorder (social phobia). treatment of generalised anxiety disorder. treatment of obsessive-compulsive disorder.
brintellix vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack
lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 6.355 mg (equivalent: vortioxetine, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hyprolose; sodium starch glycollate type a; mannitol; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.
brintellix vortioxetine (as hydrobromide) 15 mg film-coated tablet blister pack
lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 19.065 mg (equivalent: vortioxetine, qty 15 mg) - tablet, film coated - excipient ingredients: magnesium stearate; mannitol; sodium starch glycollate type a; hyprolose; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.
brintellix vortioxetine (as hydrobromide) 20 mg film-coated tablet blister pack
lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 25.42 mg (equivalent: vortioxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate type a; magnesium stearate; hyprolose; microcrystalline cellulose; mannitol; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.